{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:04:20Z","timestamp":1793271860315,"version":"4.5.0"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Gastroparesis is a disorder characterized by impaired gastric emptying and the accumulation of food in the intestines without any clear mechanical cause. Gastroparesis in critical care patients is a prevalent issue in the intensive care unit. The disruption of normal gastrointestinal motility in critically ill patients is linked to a significant risk of intolerance to enteral feeding, colonization of the gastrointestinal tract with pathogenic bacterial strains, increased permeability of the intestinal wall, translocation of the intestinal microbiota, leading to progressive malnutrition, and potential development of bacterial infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>The literature was reviewed to assess the benefits and risks associated with the use of this medication.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>The aim of the study was to treat the symptoms of gastroparesis and stimulate gastrointestinal motility. Consequently, the aim was to reduce the amount of backed-up food content in the stomach, accelerate gastrointestinal motility, and return to intestinal feeding.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Gastroparesis is a frequent issue among patients in the intensive care unit. Critical illness can lead to gastrointestinal motility disorders, causing slowed gastric emptying. This increases the risk of problems such as intolerance to enteral feeding, regurgitation, and aspiration of gastrointestinal contents into the respiratory tract, as well as colonization of the gastrointestinal tract by pathogens. Over time, impaired intestinal absorption can result in malnutrition, necessitating the initiation of parenteral nutrition.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>After analysis of the literature and published scientific reports, as well as considering their own research, it is evident that erythromycin, as a prokinetic drug, effectively enhances gastrointestinal motility. This contributes to stimulating gastric emptying in critically ill patients with gastroparesis who are hospitalized in an intensive care unit. The use of erythromycin in combination with metoclopramide and\/or itopride hydrochloride allows for a synergistic effect, leading to the quickest possible return to enteral feeding.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1440992","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T04:30:32Z","timestamp":1725856232000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Prokinetic effect of erythromycin in the management of gastroparesis in critically ill patients\u2014our experience and literature review"],"prefix":"10.3389","volume":"11","author":[{"given":"Mateusz","family":"Szczupak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart\u0142omiej","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Wierzchowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Kobak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Szczupak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Kosydar-Bochenek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Krupa-Nurcek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"ref1","first-page":"451","article-title":"Gastropareza na oddziale intensywnej terapii","volume":"53","author":"Strojek","year":"2021","journal-title":"Anestezjologia i Intensywna Terapia"},{"key":"ref2","volume-title":"Interna Szczeklika 2023. Gastropareza (Gastroparesis)","author":"Gajewski","year":"2023"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"711500","DOI":"10.3389\/fphar.2021.711500","article-title":"New developments in Prokinetic therapy for gastric motility disorders","volume":"12","author":"Camilleri","year":"2021","journal-title":"Front Pharmacol"},{"key":"ref4","first-page":"157","article-title":"Diabetic gastroparesis: do you know how to recognize and effectivety treat","author":"Krzy\u017cewska","year":"2014","journal-title":"Diabetologia Kliniczna"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/aas.12302","article-title":"Definition, prevalence, and outcome of feeding intolerance in intensive care: a systematic review and meta-analysis","volume":"58","author":"Blaster","year":"2014","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1399-6576.2008.01860.x","article-title":"Gastrointestinal symptoms in intensive care patients","volume":"53","author":"Reintam","year":"2009","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1177\/0148607114526450","article-title":"Prevalence, risk factors, clinical consequences, and treatment of enteral feed intolerance during critical illness","volume":"39","author":"Gungabissoon","year":"2015","journal-title":"JPEN J Parenteral Enteral Nutr"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cgh.2011.03.003","article-title":"Characetristisc of patients with chronic unexplained nausea and vomiting and normal gastric emttying","volume":"9","author":"Pasricha","year":"2011","journal-title":"Clin Gastrenterol Hepatl"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cgh.2014.10.027","article-title":"Does the emptier have no clothes? Diabetes, gastric emptying, and the syndrome of gastroparesis","volume":"13","author":"Pasricha","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s12664-016-0694-4","article-title":"Prevalence and predictors of delayed gastric emptying among Indian patients with long-standing type 2 diabetes mellitus","volume":"35","author":"Anudeep","year":"2016","journal-title":"Indian J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/gutjnl-2018-316405","article-title":"Association between delayed gastric emptying and upper gastrointestinal symptoms: a systematic review and meta-analysis","volume":"68","author":"Vijayvargiya","year":"2019","journal-title":"Gut"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4103\/jod.jod_69_21","article-title":"Management of Hyperglycemia in critical care","volume":"13","author":"Chawla","year":"2022","journal-title":"J Diabetol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5339\/qmj.2020.36","article-title":"Optimal dose and duration of enteral erythro-mycin as a prokinetic: a surgical intensive care experience","volume":"2020","author":"Shaikh","year":"2020","journal-title":"Qatar Med J"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/0884533614562841","article-title":"Gastric residual volume in critically ill patients: a dead marker or still alive?","volume":"30","author":"Elke","year":"2015","journal-title":"Nutr Clin Pract"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1097\/00003246-200110000-00018","article-title":"Upper digestive intolerance during enteral nutrition in critically ill patients: frequency, risk factors and complications","volume":"29","author":"Mentec","year":"2001","journal-title":"Crit Care Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1136\/gut.2010.227934","article-title":"Gastric emptying of a liquid nutrient meal in the critically ill: relationship between scintigraphic abd carbon breath test measurement","volume":"60","author":"Chapman","year":"2011","journal-title":"Gut"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/0148607105029003192","article-title":"Effect of feeding-tube properties on residual volume measurements in tube-fed patients","volume":"29","author":"Metheny","year":"2005","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1023\/a:1011935603893","article-title":"How useful is paracetamol absorption as a marker of gastric emptying? A systematic literature study","volume":"46","author":"Willems","year":"2001","journal-title":"Dig Dis Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"20160366","DOI":"10.1259\/bjr.20160366","article-title":"Evaluation of gastric blood supply in diabetic patients with gastroparesis by contrast-enhanced ultrasound","volume":"89","author":"Shen","year":"2016","journal-title":"Br J Radiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1053\/j.gastro.2011.01.046","article-title":"NIDDK gastroparesis clinical research consortium. Cellular changes in diabetic and idiopathic gastroparesis","volume":"140","author":"Grover","year":"2011","journal-title":"Gastroenterology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000358728","article-title":"Diabetic neuropathies: diagnosis and management","volume":"98","author":"Deli","year":"2013","journal-title":"Neuroendocrinology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1365-2982.2010.01659.x","article-title":"Oxidative stress: key player in gastrointestinal complications of diabetes","volume":"23","author":"Kashyap","year":"2011","journal-title":"Neurogastroenterol Motil"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"10.1111\/nmo.13018","DOI":"10.1111\/nmo.13018","article-title":"NIDDK gastroparesis clinical research consortium (GpCRC). Diabetic and idiopathic gastroparesis is associated with loss of CD206-positive macrophages in the gastric antrum","volume":"29","author":"Grover","year":"2017","journal-title":"Neurogastroenterol Motil"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/ncpgasthep0838","article-title":"Mechanisms of disease: the pathological basis of gastroparesis--a review of experimental and clinical studies","volume":"4","author":"Vittal","year":"2007","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/MAJ.0b013e31819b93e5","article-title":"Gastroparesis, pseudoachalasia and impaired intestinal motility as paraneoplastic manifestations of small cell lung cancer","volume":"338","author":"Hejazi","year":"2009","journal-title":"Am J Med Sci"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/nmo.12418","article-title":"Macrophages in diabetic gastroparesis\u2013the missing link?","volume":"27","author":"Neshatian","year":"2015","journal-title":"Neurogastroenterol Motil"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/nmo.12389","article-title":"Association of low numbers of CD206-positive cells with loss of ICC in the gastric body of patients with diabetic gastroparesis","volume":"26","author":"Bernard","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2147\/CEG.S131650","article-title":"Diabetic gastroparesis: current challenges and future prospects","volume":"11","author":"Avalos","year":"2018","journal-title":"Clin Exp Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1572-0241.2001.03454.x","article-title":"Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics","volume":"96","author":"Lee","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"ref30","first-page":"167","article-title":"Cholangiocarcinoma presenting with severe gastroparesis and pseudoachalasia","volume":"24","author":"Ghoshal","year":"2005","journal-title":"Indian J Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/j.1572-0241.2000.02076.x","article-title":"Assessment of gastric emptying using a low fat meal: establishment of international control values","volume":"95","author":"Tougas","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.cgh.2018.11.063","article-title":"Validation of diagnostic and performance characteristics of the wireless motility capsule in patients with suspected gastroparesis","volume":"17","author":"Lee","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2982.2007.01061.x","article-title":"Gastric emptying of a non-digestible solid: assessment with simultaneous smart pill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy","volume":"20","author":"Cassilly","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.coph.2008.09.009","article-title":"Prokinetics and fundic relaxants in upper functional GI disorders","volume":"8","author":"Tack","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"ref35","first-page":"47","article-title":"Leki prokinetyczne w chorobach g\u00f3rnego oecinka przewodu pokarmowego","volume":"3","author":"D\u0105browski","year":"2011","journal-title":"Gastroenterol Prakt"},{"key":"ref36","first-page":"17","article-title":"Prokinetyki w g\u00f3rnym odcinku przewodu pokarmowego \u2013 przysz\u0142o\u015b\u0107 i tera\u017aniejszo\u015b\u0107","volume":"18","author":"Lorens","year":"2011","journal-title":"Gastroentrol Pol"},{"key":"ref37","first-page":"134","article-title":"Leki prokinetyczne w Polsce \u2013 kiedy i jak stosowa\u0107","author":"Mulak","year":"2014","journal-title":"Gastroenterol Klin"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.jviscsurg.2010.06.001","article-title":"Erythromycin as a prokinetic agent: risk factors","volume":"147","author":"Berthet","year":"2010","journal-title":"J Visc Surg"},{"key":"ref39","year":""},{"key":"ref40","doi-asserted-by":"publisher","first-page":"G688","DOI":"10.1152\/ajpgi.1984.247.6.G688","article-title":"Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog","volume":"247","author":"Itoh","year":"1984","journal-title":"Am J Phys"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1126\/science.284.5423.2184","article-title":"Receptor for motilin identified in the human gastrointestinal system","volume":"284","author":"Feighner","year":"1999","journal-title":"Science"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/jac\/dkl537","article-title":"The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks","volume":"59","author":"Hawkyard","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/0016-5085(92)91097-n","article-title":"Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis","volume":"103","author":"Tack","year":"1992","journal-title":"Gastroenterology"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1111\/j.1572-0241.2000.03278.x","article-title":"The effect of erythromycin on human esophageal motility is mediated by serotonin receptors","volume":"95","author":"Koutsoumbi","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0002-9610(94)90069-8","article-title":"Erythromycin strengthens the defective lower esophageal sphincter in patients with gastroesophageal reflux disease","volume":"167","author":"Pennathur","year":"1994","journal-title":"Am J Surg"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1097\/00003246-200110000-00011","article-title":"Gastric feeding with erythromycin is equivalent to transpyloric feeding in the critically ill","volume":"29","author":"Boivin","year":"2001","journal-title":"Crit Care Med"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1097\/01.CCM.0000286397.04815.B1","article-title":"Prokinetic therapy for feed intolerance in critical illness: one drug or two?","volume":"35","author":"Nguyen","year":"2007","journal-title":"Crit Care Med"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1111\/j.1572-0241.2001.03937.x","article-title":"Effects of low doses of erythromycin on the 13C Spirulina platensis gastric emptying breath test and electrogastrogram: a controlled study in healthy volunteers","volume":"96","author":"DiBaise","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/00005176-199909000-00010","article-title":"Effect of sequential erythromycin and octreotide on antroduodenal manometry","volume":"29","author":"Di Lorenzo","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00000658-199309000-00002","article-title":"Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial","volume":"218","author":"Yeo","year":"1993","journal-title":"Ann Surg"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/00000658-199903000-00006","article-title":"Erythromycin enhances early postoperative contractility of the denervated whole stomach as an esophageal substitute","volume":"229","author":"Collard","year":"1999","journal-title":"Ann Surg"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1517\/14656566.2013.795948","article-title":"Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives","volume":"14","author":"Stevens","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"F177","DOI":"10.1136\/fn.84.3.f177","article-title":"Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants","volume":"84","author":"Ng","year":"2001","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1097\/00003246-200207000-00005","article-title":"Gastrointestinal promotility drugs in the critical care setting: a systematic review of the evidence","volume":"30","author":"Booth","year":"2002","journal-title":"Crit Care Med"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"655.e7","DOI":"10.1016\/j.jcrc.2014.12.019","article-title":"Prokinetic drugs for gastric emptying in critically ill ventilated patients: analysis through breath testing","volume":"30","author":"Hersch","year":"2015","journal-title":"J Crit Care"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clnesp.2016.04.020","article-title":"A randomised controlled feasibility and proof-of-concept trial in delayed gastric emptying when metoclopramide fails: we should revisit nasointestinal feeding versus dual prokinetic treatment: achieving goal nutrition in critical illness and delayed gastric emptying: trial of nasointestinal feeding versus nasogastric feeding plus prokinetics","volume":"14","author":"Taylor","year":"2016","journal-title":"Clinic Nut ESPEN"},{"key":"ref57","first-page":"36","article-title":"Study of erythromycin and metoclopramide in treatment of feeding intolerance of critically ill patients in intensive care unit","volume":"22","author":"Lu","year":"2010","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4103\/2249-4863.123944","article-title":"Reprogramming of gastric motility with \"pulse therapy\" (metoclopramide and erythromycin) in severe gastroparesis","volume":"2","author":"Shah","year":"2013","journal-title":"J Family Med Prim Care"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00134-007-0834-5","article-title":"Risk of Clostridium difficile diarrhoea in critically ill patients treated with erythromycin-based prokinetic therapy for feed intolerance","volume":"34","author":"Nguyen","year":"2008","journal-title":"Intensive Care Med"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/2042098611415567","article-title":"Current issues on safety of prokinetics in critically ill patients with feed intolerance","volume":"2","author":"Nguyen","year":"2011","journal-title":"Ther Adv Drug Saf"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1111\/bph.12075","article-title":"Motilin: toward a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists","volume":"170","author":"Sanger","year":"2013","journal-title":"Br J Pharmacol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2982.2008.01084.x","article-title":"Development of drugs for gastrointestinal motor disorders: translating science to clinical need","volume":"20","author":"Sanger","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ueg2.12060","article-title":"United European gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis","volume":"9","author":"Schol","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"e14174","DOI":"10.1111\/nmo.14174","article-title":"A north American perspective on the ESNM consensus statement on gastroparesis","volume":"33","author":"Camilleri","year":"2021","journal-title":"Neurogastroenterol Motil"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/apt.17466","article-title":"Review article: an analysis of the pharmacological rationale for selecting drugs to inhibit vomiting or increase gastric emptying during treatment of gastroparesis","volume":"57","author":"Sanger","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1572-0241.1993.tb07499.x","article-title":"The current role of erythromycin in the clinical management of gastric emptying disorders","volume":"88","author":"Camilleri","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/175114370901000110","article-title":"Prokinetic drugs in the intensive care unit: reviewing the evidence","volume":"10","author":"Grant","year":"2009","journal-title":"J Int Care Soc"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1136\/gut.2009.199703","article-title":"Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years","volume":"59","author":"Kashyap","year":"2010","journal-title":"Gut"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1365-2982.2009.01434.x","article-title":"Gastroparesis and functional dyspepsia: excerpts from the AGA\/ANMS meeting","volume":"22","author":"Parkman","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4103\/1319-3767.77237","article-title":"Management of diabetic gastroparesis","volume":"17","author":"Aljarallah","year":"2011","journal-title":"Saudi J Gastroenterol"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3748\/wjg.15.25","article-title":"Gastroparesis: current diagnostic challenges and management considerations","volume":"15","author":"Waseem","year":"2009","journal-title":"World J Gastroenterol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00134-005-2663-8","article-title":"Erythromycin dose of 70 mg accelerates gastric emptying as effectively as 200 mg in the critically ill","volume":"31","author":"Ritz","year":"2005","journal-title":"Intensive Care Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1440992\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T04:30:43Z","timestamp":1725856243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1440992\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":72,"alternative-id":["10.3389\/fmed.2024.1440992"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1440992","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]},"article-number":"1440992"}}